As VA brings about the goals of the Cancer Moonshot, we are working across disciplines to advance cancer treatment and execute cutting-edge research. In this session, you will learn how VA is committed to providing broad access to best-in-class cancer care across geographic barriers and advancing knowledge of molecular basis of cancer in Veterans to improve understanding of cancer etiology and effective precision treatment. Expansion of the Close to Me infusion service and implementation of the new Clinical Cancer Genetics Service are the latest examples of utilizing the VA National TeleOncology service to bring clinical expertise as close to Veterans as possible. Further, you’ll learn about the pioneering research conducted by VA in mutational signatures of cancer and how it contributes to the broader medical community's understanding of cancer genetics, benefiting both Veterans and the general population. We will explore how this research can pave the way for more effective treatments and improved outcomes. Moreover, VA oncology leaders will provide insights into VA's unwavering commitment to maintaining the highest levels of safety and quality when delivering anti-cancer therapies outside of high-complexity VA medical centers. This session offers a perspective on VA's dedication to advancing cancer care and equitable access to groundbreaking research and safe treatment delivery, with the ultimate aim that tracks to the overarching goals of Cancer Moonshot: ending cancer deaths as we know them today.